TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Thislislalsetloflquestionsltolanswerlthelquestionslofltheltextbookl"Pharmacology:lAlPatient-
CenteredlNursinglProcesslApproachl9thlEdition"litlhelpslyoultolbetterlunderstandlthelbooklcorrectly.
GetlthelrightldosageloflpharmacologylcontentltolsucceedlonlthelNCLEXlandlaslalprofessionallnurselwithl"P
harmacology:lAlPatient-
CenteredlNursinglProcesslApproach,l9thlEdition".lUsinglalstreamlinedlprototypelapproachlandlanlempha
sislonlnursinglcare,lthisltextlmakeslitleasylforltoday’slnursinglstudentsltolbetterlunderstandlthelcomplicate
dlsubjectloflpharmacology.lThelbook’sldetailedlchapterlonldosagelcalculation,lthelnursinglprocesslframew
orklforldrugltherapy,lstronglQSENlfocus,landlsummariesloflprototypeldrugslhelpldeliverlthelperfect.
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Table of Contents
l l
TableloflContents Chapterl28:lPeptides,lAntimalarial,land
Chapterl01:lDruglDevelopmentlandlE Anthelmintic
thicallConsiderations Chapterl29:lHIV-landlAIDS-
Chapterl02:lPharmacokinetics,l RelatedlDrugs
Pharmacodynamics,landlPhar Chapterl30:lTransplantlDrugsl
macogenetics Chapterl 31:lVaccineslChapterl
Chapterl03:lCulturallConsiderationsl 32:lAnticancerlDrugs
Chapterl04:lComplementarylandlAlte Chapterl33:lTargetedlTherapiesltolTreatlC
rnativelTherapies ancer
Chapterl05:lPediatriclConsiderationsl Chapterl34:lBiologiclResponsel
Chapterl06:lGeriatriclConsiderationsl Modifiers
Chapterl07:lDrugslinlSubstancelUselDi Chapterl35:lUpperlRespiratoryl
sorder Disorders
Chapterl08:lThelNursinglProcesslandlP Chapterl36:lLowerlRespiratoryl
atient-CenteredlCare Disorders
Chapterl09:lSafetylandlQualitylCh Chapterl37:lCardiaclGlycosides,lAnt
apterl10:lDruglAdministrationlCha ianginals,landlAntidysrhythmicslCha
pterl11:lDruglCalculationslChapte pterl38:lDiuretics
rl12:lFluidlVolumelandlElectrolyte Chapterl39:lAntihypertensive
s Chapterl40:lAnticoagulants,lAntiplate
Chapterl13:lVitaminlandlMinerallR lets,landlThrombolyticslChapterl41:lA
eplacement ntihyperlipidemicslandlPeripherallVas
Chapterl14:lNutritionallSupportlChapt odilators
erl15:lAdrenergiclAgonistslandlAntago Chapterl42:lGastrointestinallTractl
nists Disorders
Chapterl16:lCholinergiclAgonistslandlA Chapterl43:lAntiulcerlDrugslChapterl
ntagonists 44:lEyelandlEarlDisorderslChapterl45
Chapterl17:lStimulants :lDermatologiclDisorderslChapterl46:l
Chapterl18:lDepressantslChap Pituitary,lThyroid,lParathyroid,landlA
terl19:lAntiseizurelDrugs drenallDisorderslChapterl47:lAntidia
Chapterl20:lDrugslforlParkinsonismlandlAl betics
zheimer'slDisease Chapterl48:lUrinarylDisorderslChapte
Chapterl21:lDrugslforlNeuromuscularlD rl49:lPregnancylandlPretermlLabor
isorderslandlMusclelSpasmslChapterl2 Chapterl50:lLabor,lDelivery,landlP
2:lAntipsychoticslandlAnxiolytics ostpartum
Chapterl23:lAntidepressantslandlMoodlS Chapterl51:lNeonatallandlNewbornlC
tabilizers hapterl52:lWomen'slReproductivelHe
Chapterl24:lAntiinflammatories alth
Chapterl25:lAnalgesics Chapterl53:lMen'slReproductivelHealthlC
Chapterl26:lAntibacterials hapterl54:lSexuallylTransmittedlInfection
Chapterl27:lAntituberculars,lAntifungals,la s
ndlAntivirals Chapterl55:lAdultlandlPediatric
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
EmergencylDrugs
, TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Chapter 01: Drug Development and Ethical Considerations
l l l l l l
MULTIPLElCHOICE
1. ThelnurselislpreparingltoladministerlalschedulelIIlinjectableldruglandlisldrawingluplhalfloflthelco
ntentsloflalSingle-uselvial.lWhichlnursinglactionlislcorrect?
a. Asklanotherlnurseltolobservelandlcosignlwastinglthelremainingldruglfromlthelvial.
b. Keeplthelremaininglamountlinlthelpatient’sldrawerltolgivelatlthelnextldose.
c. Recordlthelamountlunusedlinlthelpatient’slmedicationlrecord.
d. Disposeloflthelviallwithlthelremainingldruglintolallockedlcollectionlbox.lANS
:l A
SchedulelIIldrugslarelcontrolledlsubstances,landlalllmustlbelaccountedlfor.lWhenlwastinglalportio
nloflaldrug,lanotherlnurselshouldlobservelandlcosignlthatlaldruglwaslwasted.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)lT
OP:lNURSINGlPROCESS:lNursinglIntervention
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
2. Alpatientlislprescribedlalmedicationlandlaskslthelnurselifltheldruglislavailablelinlalgenericlform.lT
helnurselunderstandslthatlalgenericlmedicationlwilllhavelalnamelthat
a. islalregisteredltrademark.
b. islalwayslcapitalized.
c. describesltheldrugslchemicallstructure.
d. islnon-
proprietary.lANS:lD
Thelgenericlnamelislthelofficial,lnon-
proprietarylnamelforlaldrug.lThelbrandlnamelisltheltrademarklnamelandlislalwayslcapitalized.lThelch
emicallnameldescribeslthelchemicallstructurelofltheldrug.
DIF:lCOGNITIVElLEVEL:lUnderstandingl(Comprehension)lT
OP:lNURSINGlPROCESS:lN/A
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
3. Alpatientlreceiveslalprescriptionlonlwhichlthelproviderlhaslnotedlthatlalgenericlmedicationlmayl
belgiven.Thelpatientlaskslthelnurselwhatlthislmeans.lWhatlwilllthelnurseltelllthelpatientlaboutlgene
ricldrugs?
a. Theylcontainlthelsamelinertlingredientslaslbrand-nameldrugs.
b. Theylhavelchemicallstructureslthatlarelidenticalltolproprietaryldrugs.
c. Theyltendltolbellesslexpensivelthanlbrand-nameldrugs.
d. Theylundergolextensiveltestinglbeforeltheylarelmarketed.lA
NS:lC
GenericldrugslarelapprovedlbylthelFDAlifltheylarelprovedltolbelbioequivalentltolthelbrand-
lnameldrug.lTheyltendltolbellesslexpensivelbecauselmanufacturerslofltheseldrugsldolnotlhaveltoldolth
elextensiveltestinglrequiredloflbrand-nameldrugslbeforelmarketing.lTheylarelnotlidenticalltolbrand-
nameldrugslandloftenlhaveldifferentlinertlingredients.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)
TOP:lNURSINGlPROCESS:lNursinglIntervention:lPatientlTeachinglMS
C:lNCLEX:lManagementloflClientlCare
4. ThelnurselreviewslinformationlaboutlaldruglandlnoteslthelinitialslUSPlafterltheldrugslofficiallname.
lThelnurselunderstandslthatlthisldesignationlindicatesltheldrug
a. islalcontrolledlsubstance.
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Thislislalsetloflquestionsltolanswerlthelquestionslofltheltextbookl"Pharmacology:lAlPatient-
CenteredlNursinglProcesslApproachl9thlEdition"litlhelpslyoultolbetterlunderstandlthelbooklcorrectly.
GetlthelrightldosageloflpharmacologylcontentltolsucceedlonlthelNCLEXlandlaslalprofessionallnurselwithl"P
harmacology:lAlPatient-
CenteredlNursinglProcesslApproach,l9thlEdition".lUsinglalstreamlinedlprototypelapproachlandlanlempha
sislonlnursinglcare,lthisltextlmakeslitleasylforltoday’slnursinglstudentsltolbetterlunderstandlthelcomplicate
dlsubjectloflpharmacology.lThelbook’sldetailedlchapterlonldosagelcalculation,lthelnursinglprocesslframew
orklforldrugltherapy,lstronglQSENlfocus,landlsummariesloflprototypeldrugslhelpldeliverlthelperfect.
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Table of Contents
l l
TableloflContents Chapterl28:lPeptides,lAntimalarial,land
Chapterl01:lDruglDevelopmentlandlE Anthelmintic
thicallConsiderations Chapterl29:lHIV-landlAIDS-
Chapterl02:lPharmacokinetics,l RelatedlDrugs
Pharmacodynamics,landlPhar Chapterl30:lTransplantlDrugsl
macogenetics Chapterl 31:lVaccineslChapterl
Chapterl03:lCulturallConsiderationsl 32:lAnticancerlDrugs
Chapterl04:lComplementarylandlAlte Chapterl33:lTargetedlTherapiesltolTreatlC
rnativelTherapies ancer
Chapterl05:lPediatriclConsiderationsl Chapterl34:lBiologiclResponsel
Chapterl06:lGeriatriclConsiderationsl Modifiers
Chapterl07:lDrugslinlSubstancelUselDi Chapterl35:lUpperlRespiratoryl
sorder Disorders
Chapterl08:lThelNursinglProcesslandlP Chapterl36:lLowerlRespiratoryl
atient-CenteredlCare Disorders
Chapterl09:lSafetylandlQualitylCh Chapterl37:lCardiaclGlycosides,lAnt
apterl10:lDruglAdministrationlCha ianginals,landlAntidysrhythmicslCha
pterl11:lDruglCalculationslChapte pterl38:lDiuretics
rl12:lFluidlVolumelandlElectrolyte Chapterl39:lAntihypertensive
s Chapterl40:lAnticoagulants,lAntiplate
Chapterl13:lVitaminlandlMinerallR lets,landlThrombolyticslChapterl41:lA
eplacement ntihyperlipidemicslandlPeripherallVas
Chapterl14:lNutritionallSupportlChapt odilators
erl15:lAdrenergiclAgonistslandlAntago Chapterl42:lGastrointestinallTractl
nists Disorders
Chapterl16:lCholinergiclAgonistslandlA Chapterl43:lAntiulcerlDrugslChapterl
ntagonists 44:lEyelandlEarlDisorderslChapterl45
Chapterl17:lStimulants :lDermatologiclDisorderslChapterl46:l
Chapterl18:lDepressantslChap Pituitary,lThyroid,lParathyroid,landlA
terl19:lAntiseizurelDrugs drenallDisorderslChapterl47:lAntidia
Chapterl20:lDrugslforlParkinsonismlandlAl betics
zheimer'slDisease Chapterl48:lUrinarylDisorderslChapte
Chapterl21:lDrugslforlNeuromuscularlD rl49:lPregnancylandlPretermlLabor
isorderslandlMusclelSpasmslChapterl2 Chapterl50:lLabor,lDelivery,landlP
2:lAntipsychoticslandlAnxiolytics ostpartum
Chapterl23:lAntidepressantslandlMoodlS Chapterl51:lNeonatallandlNewbornlC
tabilizers hapterl52:lWomen'slReproductivelHe
Chapterl24:lAntiinflammatories alth
Chapterl25:lAnalgesics Chapterl53:lMen'slReproductivelHealthlC
Chapterl26:lAntibacterials hapterl54:lSexuallylTransmittedlInfection
Chapterl27:lAntituberculars,lAntifungals,la s
ndlAntivirals Chapterl55:lAdultlandlPediatric
,TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
EmergencylDrugs
, TestlBankl-lPharmacology:lAlPatient-CenteredlNursinglProcesslApproachl(9thlEdition,l2017)
PHARMACOLOGYl9THlEDITIONlMCCUISTIONlTESTlBANK
Chapter 01: Drug Development and Ethical Considerations
l l l l l l
MULTIPLElCHOICE
1. ThelnurselislpreparingltoladministerlalschedulelIIlinjectableldruglandlisldrawingluplhalfloflthelco
ntentsloflalSingle-uselvial.lWhichlnursinglactionlislcorrect?
a. Asklanotherlnurseltolobservelandlcosignlwastinglthelremainingldruglfromlthelvial.
b. Keeplthelremaininglamountlinlthelpatient’sldrawerltolgivelatlthelnextldose.
c. Recordlthelamountlunusedlinlthelpatient’slmedicationlrecord.
d. Disposeloflthelviallwithlthelremainingldruglintolallockedlcollectionlbox.lANS
:l A
SchedulelIIldrugslarelcontrolledlsubstances,landlalllmustlbelaccountedlfor.lWhenlwastinglalportio
nloflaldrug,lanotherlnurselshouldlobservelandlcosignlthatlaldruglwaslwasted.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)lT
OP:lNURSINGlPROCESS:lNursinglIntervention
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
2. Alpatientlislprescribedlalmedicationlandlaskslthelnurselifltheldruglislavailablelinlalgenericlform.lT
helnurselunderstandslthatlalgenericlmedicationlwilllhavelalnamelthat
a. islalregisteredltrademark.
b. islalwayslcapitalized.
c. describesltheldrugslchemicallstructure.
d. islnon-
proprietary.lANS:lD
Thelgenericlnamelislthelofficial,lnon-
proprietarylnamelforlaldrug.lThelbrandlnamelisltheltrademarklnamelandlislalwayslcapitalized.lThelch
emicallnameldescribeslthelchemicallstructurelofltheldrug.
DIF:lCOGNITIVElLEVEL:lUnderstandingl(Comprehension)lT
OP:lNURSINGlPROCESS:lN/A
MSC:lNCLEX:lPhysiologicallIntegrity:lPharmacologicallandlParenterallTherapies
3. Alpatientlreceiveslalprescriptionlonlwhichlthelproviderlhaslnotedlthatlalgenericlmedicationlmayl
belgiven.Thelpatientlaskslthelnurselwhatlthislmeans.lWhatlwilllthelnurseltelllthelpatientlaboutlgene
ricldrugs?
a. Theylcontainlthelsamelinertlingredientslaslbrand-nameldrugs.
b. Theylhavelchemicallstructureslthatlarelidenticalltolproprietaryldrugs.
c. Theyltendltolbellesslexpensivelthanlbrand-nameldrugs.
d. Theylundergolextensiveltestinglbeforeltheylarelmarketed.lA
NS:lC
GenericldrugslarelapprovedlbylthelFDAlifltheylarelprovedltolbelbioequivalentltolthelbrand-
lnameldrug.lTheyltendltolbellesslexpensivelbecauselmanufacturerslofltheseldrugsldolnotlhaveltoldolth
elextensiveltestinglrequiredloflbrand-nameldrugslbeforelmarketing.lTheylarelnotlidenticalltolbrand-
nameldrugslandloftenlhaveldifferentlinertlingredients.
DIF:lCOGNITIVElLEVEL:lApplyingl(Application)
TOP:lNURSINGlPROCESS:lNursinglIntervention:lPatientlTeachinglMS
C:lNCLEX:lManagementloflClientlCare
4. ThelnurselreviewslinformationlaboutlaldruglandlnoteslthelinitialslUSPlafterltheldrugslofficiallname.
lThelnurselunderstandslthatlthisldesignationlindicatesltheldrug
a. islalcontrolledlsubstance.
